BTCS Inc. has waived the condition requiring the company's common stock price not to fall more than 10% since the tender offer began, allowing the company to continue its modified Dutch auction tender offer for its Series V Preferred Stock. The offer price range remains $0.04 to $1.00 per share, with a total purchase limit of $500,000 and an expiration date of December 15, 2026. A supplement to the offer clarifies pricing details and purchase limits. Shareholders who have already tendered do not need to act further, while others can still participate before the offer expires. This move enables BTCS to manage its capital structure amid fluctuating stock prices.
BTCS Inc.'s recent waiver of the market price condition in its Series V Preferred Stock tender offer is presented here with Pluang's market data for context. For readers following US stocks, here is Pluang's market snapshot as of Nov 10, 2026 19:16 WIB: out of 150 priced US stocks, 82 rose and 60 fell today. Notable movers include GRAB at USD 3.25 with a 1-day change of -5.52% and Pluang order activity of 99% Sell, PLUG at USD 1.57 with a 1-day change of +4.67% and 72% Sell activity, and CGC at USD 0.65 with a 1-day change of +4.37% and 79% Sell activity.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
